Patent · US Expired

Recombinant adenoviral vectors expressing chimeric fiber proteins for cell specific infection and genome integration

US7094398B1 · kind B1 · utility

10Cited by
1References
25Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 1, 2000
Grant dateAug 22, 2006
Priority date
Expiry dateJun 17, 2020

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2810/80
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides for novel chimeric Ad-vectors carrying transgene, or portions of transgenes for stable and efficient gene transfer into diverse cell types or tissues in a CAR- and/or αυβ3/5-independent manner. Also provided are methods for producing such vectors and the use thereof for gene therapy to target a specific cell type or tissue.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.